HemaSphere (Oct 2022)
Chimeric Antigen Receptor T-cell Therapy: Imaging Response Criteria and Relation to Progression-free and Overall Survival
- Michael Winkelmann,
- Kai Rejeski,
- Viktoria Blumenberg,
- Veit L. Bücklein,
- Michael Ruzicka,
- Marcus Unterrainer,
- Christian Schmidt,
- Franziska J. Dekorsy,
- Peter Bartenstein,
- Jens Ricke,
- Michael von Bergwelt-Baildon,
- Marion Subklewe,
- Wolfgang G. Kunz
Affiliations
- Michael Winkelmann
- 1 Department of Radiology, University Hospital, LMU Munich, Germany
- Kai Rejeski
- 2 Department of Medicine III, University Hospital, LMU Munich, Germany
- Viktoria Blumenberg
- 2 Department of Medicine III, University Hospital, LMU Munich, Germany
- Veit L. Bücklein
- 2 Department of Medicine III, University Hospital, LMU Munich, Germany
- Michael Ruzicka
- 2 Department of Medicine III, University Hospital, LMU Munich, Germany
- Marcus Unterrainer
- 1 Department of Radiology, University Hospital, LMU Munich, Germany
- Christian Schmidt
- 2 Department of Medicine III, University Hospital, LMU Munich, Germany
- Franziska J. Dekorsy
- 3 Department of Nuclear Medicine, University Hospital, LMU Munich, Germany
- Peter Bartenstein
- 3 Department of Nuclear Medicine, University Hospital, LMU Munich, Germany
- Jens Ricke
- 1 Department of Radiology, University Hospital, LMU Munich, Germany
- Michael von Bergwelt-Baildon
- 2 Department of Medicine III, University Hospital, LMU Munich, Germany
- Marion Subklewe
- 2 Department of Medicine III, University Hospital, LMU Munich, Germany
- Wolfgang G. Kunz
- 1 Department of Radiology, University Hospital, LMU Munich, Germany
- DOI
- https://doi.org/10.1097/HS9.0000000000000781
- Journal volume & issue
-
Vol. 6,
no. 10
p. e781
Abstract
No abstracts available.